Marco Donia, Professor at University of Copenhagen, shared a post by Heinz Läubli, Physician Scientist at the University of Basel, adding:
“Overcoming resistance to Checkpoint Blockade with:
1. Cell Therapies
2. Bispecific Engagers
Our new review in Clinical Cancer Research at link below
Thanks to the great team from University of Basel.”
Quoting Heinz Läubli‘s post:
“Our recent review on how we can overcome resistance to immune checkpoint blockade. Together with David König, Marco Donia, Mascha Binder, and Alfred Zippelius.”
Title: Cell Therapies and Bispecific Engagers: Redefining Strategies Against Checkpoint Resistance
Authors: Heinz Läubli, David König, Marco Donia, Mascha Binder, Alfred Zippelius
Read the Full Article.
Other articles featuring Marco Donia.